BIOCRYST PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Biocryst Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 207M shares, a 1.13% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 207M +2.32M +1.13% Oct 31, 2024 10-Q 2024-11-05
Q2 2024 207M +17.4M +9.18% Jul 31, 2024 10-Q 2024-08-06
Q1 2024 206M +17.4M +9.23% Apr 30, 2024 10-Q 2024-05-07
Q3 2023 205M +18.4M +9.86% Oct 31, 2023 10-Q 2023-11-08
Q2 2023 189M +3.55M +1.91% Jul 28, 2023 10-Q 2023-08-07
Q1 2023 189M +3.35M +1.81% Apr 28, 2023 10-Q 2023-05-08
Q4 2022 188M +3.79M +2.05% Jan 31, 2023 10-K 2023-02-27
Q3 2022 186M +6.49M +3.61% Oct 31, 2022 10-Q 2022-11-04
Q2 2022 186M +7.08M +3.96% Jul 29, 2022 10-Q 2022-08-05
Q1 2022 186M +7.89M +4.44% Apr 29, 2022 10-Q 2022-05-09
Q4 2021 185M +7.48M +4.22% Jan 31, 2022 10-K 2022-02-28
Q3 2021 180M +3.37M +1.91% Oct 29, 2021 10-Q 2021-11-04
Q2 2021 179M +2.3M +1.31% Jul 30, 2021 10-Q 2021-08-09
Q1 2021 178M +23.4M +15.2% Apr 30, 2021 10-Q 2021-05-07
Q4 2020 177M +23M +14.9% Jan 31, 2021 10-K 2021-03-01
Q3 2020 177M +66.1M +59.9% Oct 31, 2020 10-Q 2020-11-06
Q2 2020 177M +66.1M +59.9% Jul 31, 2020 10-Q 2020-08-10
Q1 2020 154M +43.9M +39.8% Apr 30, 2020 10-Q 2020-05-11
Q4 2019 154M +44M +40% Jan 31, 2020 10-K 2020-03-13
Q3 2019 110M +797K +0.73% Oct 31, 2019 10-Q 2019-11-08
Q2 2019 110M +11.5M +11.6% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 110M +11.6M +11.7% Apr 30, 2019 10-Q 2019-05-09
Q4 2018 110M +11.6M +11.7% Jan 31, 2019 10-K 2019-03-14
Q3 2018 110M +11.2M +11.4% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 98.9M +18.5M +23% Jul 31, 2018 10-Q 2018-08-09
Q1 2018 98.7M +18.3M +22.8% Apr 30, 2018 10-Q 2018-05-09
Q4 2017 98.6M +24.7M +33.3% Jan 31, 2018 10-K 2018-03-12
Q3 2017 98.4M +24.6M +33.4% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 80.4M +6.73M +9.13% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 80.4M +6.73M +9.13% Apr 30, 2017 10-Q 2017-05-08
Q4 2016 74M +379K +0.52% Jan 31, 2017 10-K 2017-02-27
Q3 2016 73.8M +421K +0.58% Oct 31, 2016 10-Q 2016-11-08
Q2 2016 73.7M +461K +0.63% Jul 31, 2016 10-Q 2016-08-08
Q1 2016 73.7M +1.17M +1.62% Apr 30, 2016 10-Q 2016-05-09
Q4 2015 73.6M +1.26M +1.74% Jan 31, 2016 10-K 2016-02-26
Q3 2015 73.3M +1.47M +2.05% Oct 31, 2015 10-Q 2015-11-06
Q2 2015 73.2M +1.48M +2.07% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 72.5M +12.5M +20.7% Apr 30, 2015 10-Q 2015-05-08
Q4 2014 72.3M +12.9M +21.8% Jan 31, 2015 10-K 2015-03-02
Q3 2014 71.9M +12.8M +21.6% Oct 31, 2014 10-Q 2014-11-07
Q2 2014 71.8M +17.5M +32.3% Jul 31, 2014 10-Q 2014-08-08
Q1 2014 60.1M +6.92M +13% Apr 30, 2014 10-Q 2014-05-09
Q4 2013 59.4M +8.46M +16.6% Jan 31, 2014 10-K 2014-03-10
Q3 2013 59.1M +8.21M +16.1% Oct 31, 2013 10-Q 2013-11-08
Q2 2013 54.2M +3.74M +7.41% Jul 31, 2013 10-Q 2013-08-08
Q1 2013 53.1M +3.98M +8.09% Apr 30, 2013 10-Q 2013-05-09
Q4 2012 50.9M +4.89M +10.6% Jan 31, 2013 10-K 2013-03-11
Q3 2012 50.9M +5.67M +12.5% Oct 31, 2012 10-Q 2012-11-08
Q2 2012 50.5M +5.34M +11.8% Jul 31, 2012 10-Q 2012-08-08
Q1 2012 49.2M Apr 30, 2012 10-Q 2012-05-08
Q4 2011 46M Jan 31, 2012 10-K 2012-03-06
Q3 2011 45.2M Nov 1, 2011 10-Q 2011-11-03
Q2 2011 45.1M Aug 1, 2011 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.